- Construction and Validation of a Prognostic Risk Model for Triple-Negative Breast Cancer Based on Autophagy-Related Genes
Cheng Yan et al, 2022, Frontiers in Oncology CrossRef - Metabolic characterisation of transglutaminase 2 inhibitor effects in breast cancer cell lines
Mariana Gallo et al, 2023, The FEBS Journal CrossRef - Glucose Metabolism in Cancer: The Warburg Effect and Beyond
Sminu Bose et al, 2021, The Heterogeneity of Cancer Metabolism CrossRef - Case Report of a Breast Mass with Three Types of Malignant Tumors—Squamous Cell Carcinoma, Invasive Ductal Carcinoma, and Breast Sarcoma
Chao Li et al, 2021, OncoTargets and Therapy CrossRef - Immature natural killer cells promote progression of triple-negative breast cancer
Gatha Thacker et al, 2023, Science Translational Medicine CrossRef - Identification and panoramic analysis of drug response-related genes in triple negative breast cancer using as an example NVP-BEZ235
Jia Feng et al, 2023, Scientific Reports CrossRef - Identification of a Novel Glycolysis-Related Gene Signature for Predicting Breast Cancer Survival
Dai Zhang et al, 2021, Frontiers in Oncology CrossRef - Multi-Omic Approaches to Breast Cancer Metabolic Phenotyping: Applications in Diagnosis, Prognosis, and the Development of Novel Treatments
Nuria Gómez-Cebrián et al, 2021, Cancers CrossRef - Facts and Perspectives: Implications of tumor glycolysis on immunotherapy response in triple negative breast cancer
Ashley Schreier et al, 2023, Frontiers in Oncology CrossRef - Development of a Gene Risk Signature for Patients of Pancreatic Cancer
Tao Liu et al, 2022, Journal of Healthcare Engineering CrossRef - Gene Expression Signatures of the Tumor Microenvironment: Relation to Tumor Phenotypes and Progress in Breast Cancer
Elisabeth Wik et al, 2022, Biomarkers of the Tumor Microenvironment CrossRef